An HIV vaccine stimulating T cell and antibody responses

DISEASE CATEGORY: Infectious disease

INDICATION: HIV/AIDS

Adding T cell-stimulating heterologous viral vectors (HVVs) to an adjuvanted, HIV env-based HIV vaccine could improve the prevention of HIV infection. The HVVs comprise a vesicular

Read the full 300 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE